Roh, J., Kim, E. H., Park, H. B., & Park, J. Y. (2013). The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin increases cisplatin antitumor activity by inducing p53-mediated apoptosis in head and neck cancer. Nature Publishing Group.
Citação norma ChicagoRoh, J-L, E H. Kim, H B. Park, and J Y. Park. The Hsp90 Inhibitor 17-(allylamino)-17-demethoxygeldanamycin Increases Cisplatin Antitumor Activity By Inducing P53-mediated Apoptosis in Head and Neck Cancer. Nature Publishing Group, 2013.
Citação norma MLARoh, J-L, E H. Kim, H B. Park, and J Y. Park. The Hsp90 Inhibitor 17-(allylamino)-17-demethoxygeldanamycin Increases Cisplatin Antitumor Activity By Inducing P53-mediated Apoptosis in Head and Neck Cancer. Nature Publishing Group, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.